Navigation Links
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
Date:12/9/2012

low patients the convenience of a completely oral, highly effective regimen for treatment of multiple myeloma."

Dr. Kumar will present this study in an oral presentation on Monday, December 10, at 7:15 a.m. EST at the Georgia World Congress Center in the Thomas Murphy Ballroom 2-3, Level 5, Building B.

Pomalidomide in Combination with Low-Dose Dexamethasone: Demonstrates a Significant Progression Free Survival and Overall Survival Advantage, in Relapsed/Refractory MM: A Phase III, Multicenter, Randomized, Open-Label Study [LBA 6]

An advanced trial comparing therapeutic options for refractory multiple myeloma finds that combination treatment with pomalidomide and low-dose dexamethasone may be superior to high-dose dexamethasone alone for patients with resistant and relapsed disease.

Multiple myeloma (MM) causes abnormal plasma cells to accumulate in the bone marrow, interfering with normal blood cell production and increasing the risk of infection and abnormal bleeding. Current treatments include combinations of steroid therapies like dexamethasone, which reduces inflammation and manages the immune response with targeted therapies like bortezomib and lenalidomide that inhibit tumor growth and reproduction. However, many patients eventually become resistant to these standard therapies and therefore have a poor prognosis. Since there are few treatment options available for these difficult-to-treat patients, research has aimed to identify new therapy combinations and disease targets that may lead to better results.

Early trials of a novel immunomodulatory drug called pomalidomide have shown some evidence of activity in these relapsed and treatment-resistant patients. Pomalidomide offers an effective mechanism against resistant myeloma because it directly targets the disease in multiple ways. It not only encourages the immu
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Researchers develop novel 3-D culture system for inflammatory breast cancer
2. ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
3. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
4. Novel mechanism through which normal stromal cells become cancer-promoting cells identified
5. Novel breast screening technology increases diagnostic accuracy
6. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
7. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
8. Novel treatment strategies for epilepsy
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
11. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Electric™ Energy Straws, an exciting new brand of ... and will be the lead sponsor on Munoz’s Chevy #26 ... Speedway. Munoz, who is part of Andretti Autosports’ fantastic five ... race, qualifying to be named the 2013 Indy 500 Fastest ... race. , While Munoz is grabbing headlines around the ...
(Date:5/24/2013)... The point-of-care (POC) diagnostics market encompasses ... central laboratory, by other healthcare professionals, patient self-testers ... consumers. This includes products that test blood glucose ... cardiovascular disease and cancer, as well as hospital ... and emergency departments. , Critical analysis and 5-year ...
(Date:5/24/2013)... is available in German . ... "alpha-synuclein" aggregates and accumulates within neurons. Specific areas of ... and advances. The mechanism underlying this pathological progression is ... protein (or abnormal forms of it) along nerve projections ... the German Center for Neurodegenerative Diseases (DZNE) in Bonn ...
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... for the seventh commencement ceremony of American University ... Fisher Hall in Lincoln Center. , This was the ... master of ceremonies Dick Woodward, AUA’s Senior Vice President ... graduate processional and Dr. Reza Sanii, Associate Dean of ...
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- Nearly three ... such as constipation and diarrhea, but these issues ... new study finds. Researchers from Loyola University ... bowel issues are due to physiological and hormonal ... women take during pregnancy also can play a ...
Breaking Medicine News(10 mins):Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 2Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 3Health News:Proteins in migration 2Health News:Proteins in migration 3Health News:Proteins in migration 4Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2
... Your mother,s wrinkles or lack there of, ... age. In fact, a new study claims just the ... genetic make-up, certain environmental factors can add years to ... web-based version of Plastic and Reconstructive Surgery , ...
... geographic reach, expand access to patients - PRINCETON, ... CVD ), one of the world,s largest and most ... of three new clinical development offices in Kiev, Ukraine; ... the company,s global presence. Covance has been providing ...
... footage from Tucson, AZ, implicates a third Planned Parenthood ... video, UCLA student Lila Rose and her ... where Rose tells the nurse that Stollar, posing as ... nurse disregards the age difference and even cautions Stollar ...
... announces new updates to the NCCN Guidelines for ... Noteworthy additions include new recommendations on when to ... the use of PET/CT scanning for evaluative purposes, ... surgery. , FORT WASHINGTON, Pa., Feb. 3 ...
... 3 McKenna Long & Aldridge LLP (MLA) is ... of Defense for Homeland Defense, has joined the firm ... role, he will support the firm,s Life Sciences and ... Security and Disaster Planning, in addition to helping clients ...
... AMERIGROUP Corporation (NYSE: AGP ) announced today ... Chief Compliance Officer, a position charged with responsibility that ... and regulations. "John Finley,s valuable experience in government and ... out his duties at AMERIGROUP," said John E. Littel, ...
Cached Medicine News:Health News:Divorce, antidepressants, or weight gain/loss can add years to your face 2Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 2Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 3Health News:New Undercover Video Shows Tucson Planned Parenthood Hiding Rape of 15-Year-Old Girl 2Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 2Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 3Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 4Health News:Former Assistant Secretary of Defense for Homeland Defense Joins McKenna Long & Aldridge LLP 2Health News:AMERIGROUP Names Finley Chief Compliance Officer 2
(Date:5/23/2013)... -- More than half of women diagnosed with early ... still have excellent outcomes. To educate women, Agendia, Inc. ... sources of online consumer information about breast cancer genomic ... recently diagnosed women with information sources, to help them ... "We anticipate these innovative social media campaigns will encourage ...
(Date:5/23/2013)... MONICA, Calif. , May 23, 2013 ... a program that would have required them to obtain ... today by Consumer Watchdog and Whatley Kallas LLC.  ... Diego Superior Court, alleged that Blue Cross,s mandatory mail ... patients, threatening their health and privacy. "This ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... 2011  Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today ... edoxaban, a direct oral once-daily Factor Xa inhibitor, significantly ... total knee or hip arthroplasty, when compared to enoxaparin. ... composite of deep vein thrombosis (DVT) and pulmonary embolism ...
... SHANGHAI, Dec. 12, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: ... medical-device research and development outsourcing company with operations in ... of its fifth Life Science and Chemistry Awards, held ... Beijing. The theme of this year,s awards ...
Cached Medicine Technology:Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 2Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 3Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 4Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 5WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards 2WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards 3
Liberty Single Piece PMMA Lens with UV Absorber....
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
... a sterile nonpyrogenic, transparent viscoelastic solution of ... 12 mg/ml of high molecular weight (greater ... in physiological saline. In the limit of ... cps (105 Pa s) at 25 C ...
... Plus is the preferred viscoelastic for phacoemulsification ... reliably works from the start to the ... cohesive profile of this viscoelastic is the ... associated with phacoemulsification remove only a fraction ...
Medicine Products: